Glycogen synthase kinase-3 inhibitors
US7378432B2 · kind B2 · utility
5Cited by
6References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2005 |
| Grant date | May 27, 2008 |
| Priority date | — |
| Expiry date | Feb 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2299/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.